These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 15340142)
1. Biography of Barry S. Coller. Brownlee C Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13111-3. PubMed ID: 15340142 [No Abstract] [Full Text] [Related]
3. Management of coronary artery perforation in patients receiving abciximab. Del Campo C; Zelman R Catheter Cardiovasc Interv; 2001 Sep; 54(1):139-40. PubMed ID: 11553964 [No Abstract] [Full Text] [Related]
4. [Quick resolution with abciximab of giant coronary thrombus]. Delcán Domínguez JL; García Fernández E; Guerrero Sanz JE Rev Esp Cardiol; 2002 May; 55(5):536. PubMed ID: 12015935 [No Abstract] [Full Text] [Related]
5. Acute platelet inhibition with abciximab does not reduce in-stent restenosis. Ikeda U; Hojo Y; Katsuki T; Shimada K Circulation; 2000 Oct; 102(15):E110. PubMed ID: 11023951 [No Abstract] [Full Text] [Related]
6. Acute platelet inhibition with abciximab does not reduce in-stent restenosis. Malik I; Poullis M Circulation; 2000 Oct; 102(15):E110. PubMed ID: 11023950 [No Abstract] [Full Text] [Related]
7. Routine use of abciximab in coronary stenting? Stables RH Lancet; 1998 Jul; 352(9122):81-2. PubMed ID: 9672267 [No Abstract] [Full Text] [Related]
8. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Use of abciximab: comparative economic data. Mark DB; Simons TA Am Heart J; 1999 May; 137(5):S123-5. PubMed ID: 10220613 [No Abstract] [Full Text] [Related]
9. The EPILOG trial. Abciximab prevents ischemic complications during angioplasty. Evaluation in PTCA to improve Long-Term Outcome with Abciximab GP IIb/IIIa Blockade. Roe MT; Moliterno DJ Cleve Clin J Med; 1998 May; 65(5):267-72. PubMed ID: 9599910 [No Abstract] [Full Text] [Related]
10. Integrin beta3 blockade with abciximab and protection from myocardial ischemic events. Conrad ME; Umbreit JN; Moore EG JAMA; 1998 Jan; 279(3):195-6. PubMed ID: 9438735 [No Abstract] [Full Text] [Related]
11. Attainment and maintenance of platelet inhibition through standard dosing of abciximab in patients undergoing percutaneous coronary intervention. Kereiakes DJ Circulation; 2000 Dec; 102(25):E186. PubMed ID: 11120710 [No Abstract] [Full Text] [Related]
12. Readministration of abciximab in percutaneous coronary intervention. Fry ET J Invasive Cardiol; 1999 Apr; 11(4):251-8. PubMed ID: 10745525 [TBL] [Abstract][Full Text] [Related]
13. Rails, ReoPro, and the real world. O'Neill WW Cathet Cardiovasc Diagn; 1998 Jan; 43(1):7-8. PubMed ID: 9473178 [No Abstract] [Full Text] [Related]
14. A preferred reperfusion strategy for acute myocardial infarction. Topol EJ; Neumann FJ; Montalescot G J Am Coll Cardiol; 2003 Dec; 42(11):1886-9. PubMed ID: 14662246 [No Abstract] [Full Text] [Related]
15. Recovery of coronary flow and left ventricular function after abciximab. Mak KH; Neumann FJ; Blasini MR; Schmitt MC; Alt ME; Dirschinger MJ; Gawaz MM; Kastrati MA; Schömig MA Circulation; 1999 Nov; 100(22):e110. PubMed ID: 10578011 [No Abstract] [Full Text] [Related]
16. Prevention of restenosis after angioplasty. Cahill MR; Macey MG; Dawson JR; Newland AC Lancet; 1994 May; 343(8909):1361. PubMed ID: 7910347 [No Abstract] [Full Text] [Related]
17. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. An industry perspective on health economics studies. Anderson KM; Bala MV; Weisman HF Am Heart J; 1999 May; 137(5):S129-32. PubMed ID: 10220615 [No Abstract] [Full Text] [Related]
18. Effect of abciximab on myocardial salvage in patients with acute myocardial infarction undergoing primary angioplasty. Lee CW; Moon DH; Hong MK; Lee JH; Choi Si; Yang HS; Kim JJ; Park SW; Park SJ Am J Cardiol; 2002 Dec; 90(11):1243-6. PubMed ID: 12450607 [No Abstract] [Full Text] [Related]
19. Potential role of abciximab in ischemic cerebrovascular disease. Winkley JM; Adams HP Am J Cardiol; 2000 Apr; 85(8A):47C-51C. PubMed ID: 10793180 [TBL] [Abstract][Full Text] [Related]